We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Challenges of referral, diagnosis and management of axial spondylarthritis.
- Authors
Alnaqbi, Khalid Abdalla; Al Araimi, Tariq; Al Emadi, Samar; Al Rayyes, Hanan; Saleh, Khuloud; Bashir, Khlood; Baraliakos, Xenofon
- Abstract
Background: There are many challenges in the referral, diagnosis, and management of patients with suspected axial spondylarthritis (AxSpA) worldwide. Gulf-REDMAS comprises a group of expert rheumatologists from the Gulf countries who convened to create and disseminate a survey to understand the aforementioned challenges with the main aim to fill the evidence gap. Materials and methods: An anonymous online survey consisting of 35 multiple choice closed questions that lasted for 1 month was circulated among practicing rheumatologists in the Gulf countries (calculated sample size was 101). Results: One hundred thirty-two rheumatologists completed the survey from 371 rheumatologists in the region. The majority of responders (88%) noted that they faced delays in the referral of AxSpA patients to their clinic, with the main reason being a 'lack of disease awareness by primary care physicians' (56%). The survey respondents surmised that the leading reasons for non-rheumatology specialists' reluctance to refer patients with suspected AxSpA included 'lack of awareness of long-term complications of spondylarthritis' (34%), and 'some non-rheumatology specialists think they can treat and diagnose AxSpA without the need to refer to a rheumatologist' (28%). Two-thirds of survey respondents (66%) highlighted that the greatest challenge being 'patients who present with atypical symptoms such as: <3 months back pain, chronic back pain occurring >45 years of age, or chronic back pain with ≥1 spondyloarthritis features but without sacroiliitis on imaging' (51% of responders who highlighted they faced a challenge). The main patient-related challenges to management of AxSpA were: 'patients cannot access the medication as it is unavailable in my hospital/clinic pharmacy' (31%, first reason) and 'patients may have fears of drug side effects (39.6%, second reason). Conclusion: Responses to this survey highlighted several challenges in the referral, diagnosis, and management of AxSpA patients. Future recommendations that should be implemented to address these challenges
- Subjects
PERSIAN Gulf; SPONDYLOARTHROPATHIES; DRUG side effects; BACKACHE; RHEUMATOLOGISTS; CHRONIC pain
- Publication
Saudi Medical Journal, 2022, Vol 43, Issue 6, p637
- ISSN
0379-5284
- Publication type
Article